Bone Morphogenetic Protein Receptors, Type II
"Bone Morphogenetic Protein Receptors, Type II" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subtype of bone morphogenetic protein receptors with low affinity for BONE MORPHOGENETIC PROTEINS. They are constitutively active PROTEIN-SERINE-THREONINE KINASES that can interact with and phosphorylate TYPE I BONE MORPHOGENETIC PROTEIN RECEPTORS.
| Descriptor ID |
D052006
|
| MeSH Number(s) |
D08.811.913.696.620.682.700.109.750 D12.776.543.750.750.400.049.750
|
| Concept/Terms |
Bone Morphogenetic Protein Receptors, Type II- Bone Morphogenetic Protein Receptors, Type II
- BMP Type II Receptors
- Receptor, Type II BMP
- BMPR2 Receptor
- Receptor, BMPR2
- Bone Morphogenetic Protein Receptor II
- Bone Morphogenetic Protein Receptor Type II
- BMP Type II Receptor
- BMPR-II Receptor
- BMPR II Receptor
- Receptor, BMPR-II
|
Below are MeSH descriptors whose meaning is more general than "Bone Morphogenetic Protein Receptors, Type II".
Below are MeSH descriptors whose meaning is more specific than "Bone Morphogenetic Protein Receptors, Type II".
This graph shows the total number of publications written about "Bone Morphogenetic Protein Receptors, Type II" by people in this website by year, and whether "Bone Morphogenetic Protein Receptors, Type II" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2005 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2021 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Bone Morphogenetic Protein Receptors, Type II" by people in Profiles.
-
Bisserier M, Katz MG, Bueno-Beti C, Brojakowska A, Zhang S, Gubara S, Kohlbrenner E, Fazal S, Fargnoli A, Dorfmuller P, Humbert M, Hata A, Goukassian DA, Sassi Y, Hadri L. Combination Therapy with STAT3 Inhibitor Enhances SERCA2a-Induced BMPR2 Expression and Inhibits Pulmonary Arterial Hypertension. Int J Mol Sci. 2021 Aug 24; 22(17).
-
Tatius B, Wasityastuti W, Astarini FD, Nugrahaningsih DAA. Significance of BMPR2 mutations in pulmonary arterial hypertension. Respir Investig. 2021 Jul; 59(4):397-407.
-
Sengle G, Ono RN, Lyons KM, B?chinger HP, Sakai LY. A new model for growth factor activation: type II receptors compete with the prodomain for BMP-7. J Mol Biol. 2008 Sep 12; 381(4):1025-39.
-
Crowley AR, Mehta SS, Hembree MJ, Preuett BL, Prasadan KL, Sharp SW, Yew H, McFall CR, Benjes CL, Tulachan SS, Gittes GK, Snyder CL. Bone morphogenetic protein expression patterns in human esophageal atresia with tracheoesophageal fistula. Pediatr Surg Int. 2006 Feb; 22(2):154-7.
-
D?lot EC, Bahamonde ME, Zhao M, Lyons KM. BMP signaling is required for septation of the outflow tract of the mammalian heart. Development. 2003 Jan; 130(1):209-20.